VII BiotechHealth Annual Symposium
22 OCTOBER 2020
8:45h WEST
i3S - Porto, Portugal
ABOUT
VII BiotechHealth Annual Symposium
From Bench to Bedside:
Found in Translation
What has been done to fill the gap between research and clinic?
The VII BiotechHealth Annual Symposium will be a flagship meeting where you can connect and discuss the hot topics of translational research together with other participants who believe that solutions are only a step or two away.
Be updated with emerging ideas and communicate, collaborate and network with a renowned and eclectic panel of national and international speakers focused on the translation from bench to bedside. Medical professionals, pharma industry representatives, and scientists from diversified areas will open and encourage the debate between the scientific and clinic communities. Enhance your knowledge and participate in this discussion about challenges and possible solutions for the translational scenario.
Building bridges and breaking barriers between science and clinic is our ambition.
Embrace the challenge and participate in our Symposium to help to make the way to the future!
​
Our
Speakers
João F. Mano
CICECO - Aveiro Institute of Materials
University of Aveiro, Portugal
João F. Mano is a full professor at the Department of Chemistry of the University of Aveiro (Portugal). He is the director of both Master and Doctoral Degrees in Biotechnology at the Univ. of Aveiro. He belongs to the associate laboratory CICECO – Aveiro Institute of Materials where he is directing the COMPASS Research Group.
His current research interests include the use of biomaterials and cells towards the development of transdisciplinary concepts especially aimed at being used in regenerative and personalised medicine. João F. Mano is author of 640+ papers in international journals. He filed 6 patents as senior inventor. He is the co-founder and chairman of METATISSUE, a company developing human-derived hydrogels for 3D cells culture. He is the Editor-in-Chief of Materials Today Bio (Elsevier), and belongs to the editorial board of about 10 in other international journals. He has been coordinating many national and European research projects, including two advanced grants from the European Research Council. He was invited to present more than 100 invited talks in international conferences. João F. Mano has received different honours and awards, including an honoris causa doctorate from Univ. of Lorraine (2019) and was elected fellow of the European Academy of Sciences (2020).
Lorena Diéguez
INL - International Iberian Nanotechnology Laboratory,
Braga, Portugal
Lorena Diéguez is since 2018 the leader of the Medical Devices research group and currently the coordinator of the Health Cluster at INL. Her team is devoted to the development of medical devices for minimally invasive diagnosis in close collaboration with hospitals towards translational medical research. She is currently focused on the development of microfluidic systems with integrated nanobiosensors for the isolation and characterization of biomarkers from body fluids, towards fast and efficient disease diagnostics. The group also works on the development of organ-on-a-chip 3D models. She is also very interested in translating her technology from the lab to the clinic and has founded the spin-off RUBYnanomed in the field of liquid biopsy. Currently, she is also the Chair of the Working Group in Medical Devices at the ETPN (European Technology Platform in Nanomedicine).
She obtained her Bachelors in Physics and her Masters in Optoelectronics at the University of Santiago de Compostela in 2005, then completed her Masters in Nanotechnology at the University of Barcelona in 2007 and her PhD in biosensors at the Institute for Bioengineering of Catalonia and the ETH Zürich. Her postdoc at the University of South Australia (2010-2013) was devoted to the study of rare cells from biological samples using microfluidics. She has been involved in lecturing, science outreach and innovation programs in Portugal, Spain, Switzerland, Germany, UK, Australia and USA.
Bruno Silva-Santos
iMM - Instituto de Medicina Molecular
Lisbon, Portugal
Bruno Silva-Santos is a Group Leader and Vice-Director of Instituto de Medicina Molecular (iMM), and Associate Professor at the Faculty of Medicine of the University of Lisbon (Portugal). He did his PhD in Immunology with Michael J. Owen at Cancer Research UK (The London Research Institute, 1998-2002), and trained as a post-doc with Adrian Hayday at King’s College London (2002-2005). Since establishing his independent group in 2006 at iMM in Lisbon, Bruno Silva-Santos has received Starting and Consolidator Grants from the European Research Council (ERC) and Installation and Young Investigator Grants from the European Molecular Biology Organization (EMBO).
His research is mostly dedicated to gamma-delta T cells, having dissected novel molecular mechanisms of their differentiation and tumour cell recognition, published in circa 90 papers in top international peer-reviewed journals, including Science, Nature and Nature Immunology. In 2019, Bruno Silva-Santos was elected EMBO Member in recognition of his scientific contributions. His translational work on Immuno-Oncology was further recognized with various awards and the nomination as Honorary Member of the European Academy of Tumour Immunology. His work also constituted the basis for a start-up company (founded in 2013) focused on cancer immunotherapy, Lymphact, in which he presided the Scientific Council; and was acquired in 2018 by GammaDelta Therapeutics (London, UK), where he now serves in the Scientific Advisory Board.
María J. Alonso
CIMUS
University of Santiago de Compostela, Spain
María José Alonso’s lab has pioneered numerous discoveries in the field of Pharmaceutical Nanotechnology and nanomedicine. She has coordinated several research consortia financed by the WHO, the Gates Foundation and the European Commission. She is the author of 290 scientific contributions with more than 29,400 cites (H factor 90) and the inventor of 22 patent families. Because of the quality of her scientific articles she has been among the TOP TEN in Pharmacology (Times Higher Education international ranking, 2010). Recently, she become part of the “Power List” of the most influential researchers in the field of Biopharmaceuticals (The Medicine Maker, 2020).
She has served to the Release Society (CRS) for 15 years and she is currently Past President of the Controlled Release Society (CRS). She is also Editor-in-Chief of the Drug Delivery and Translational Research, an official journal of the CRS, and she is part of the editorial board of 11 journals.
She has received 30 awards, among them the “Jaime I Award, category New technologies; the “Castelao Medal” granted by the President of the Xunta de Galicia, the Medal of the General Council of Pharmacists, and many other awards granted by scientific organizations, such as the “Founders Award” and the “Outstanding Service Award” of the CRS.
She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and a Fellow of the Controlled Release Society, a member of the Royal Academy of Pharmacy of Spain, the Royal Academy of Sciences of Galicia, the Royal Academy of Pharmacy in Galicia and a member of the US National Academy of Medicine (NAM). She was the Vice-rector of Research and Innovation of the USC (2006-10).
.jpg)
Catarina Brito
iBET/ITQB NOVA
NOVA University Lisbon, Portugal
Catarina Brito is a Principal Investigator at iBET (PT), heading the Advanced Cell Models Lab of the Animal Cell Technology Unit of iBET and ITQB-NOVA since 2014. Catarina holds a PhD in Biochemistry by ITQB-NOVA (PT). Her PhD, in glycobiology and intracellular trafficking in human cells, was done at ITQB and as a visiting student at Institut Jacques Monod (FR).
She joined iBET in 2007, initially as a postdoc working in human Stem Cell bioprocessing, and later as a Senior Project Manager of academic and industrial collaborations, developing preclinical cell models and bioassays.
Her research is mostly translational, dedicated to the development of advanced human cell models (employing induced pluripotent stem cells and other patient-derived cells) to depict the deregulation of the cellular microenvironment in disease progression and evaluate its role in therapeutic response.
Ana Catarina Silva
Gladstone Institutes,
San Francisco, USA
Ana Silva is an alumni of the BiotechHealth doctoral program.
​
She is currently a postdoctoral fellow in cardiac bioengineering at Gladstone Institutes. Silva integrates Dr. Todd C. McDevitt laboratory since 2016 and her current research is focused on the development of organoid models that allow the co-development of tissues derived from distinct germ layers (multilineage organoids), in order to create in vitro systems that better mimic the tissues crosstalk processes ongoing during development.
In addition to science, Silva loves illustration and visual science communication, being an aspiring (science) illustrator.
.jpg)
Albert van den Berg
MESA+ Institute for Nanotechnology,
University of Twente, Netherlands
Albert van den Berg received his MSc in applied physics in 1983, and his PhD in 1988 both at the University of Twente, the Netherlands. From 1988-1993 he worked in Neuchatel, Switzerland, at the CSEM and the University (IMT) on miniaturized chemical sensors. In 2000 he was appointed as full professor on Miniaturized Systems for (Bio)Chemical Analysis in the faculty of Electrical Engineering and part of the MESA+ Institute for Nanotechnology. In 1994 he initiated together with Prof. Bergveld the international MicroTAS conference series. He published over 450 peer reviewed publications (H=63 WoS, H=83 Google Scholar) a.o. in Science, Nature, PNAS, NanoLetters etc, and from his group > 10 spin-off companies started. He received several honors and awards such as Simon Stevin (2002), two ERC Advanced (2008, 2015) and four ERC Proof of Concept (2011, 2013, 2016, 2020) grants, Simon Stevin award (engineering sciences), Spinoza prize (2009), Distinguished University Professor (Twente, 2010), Distinguished Professor (South China Normal University SNCU (China), 2012), Consulting Professor at Northwestern Polytechnic University NPU (China), 2017) and member of the Royal Dutch Academy of Sciences (KNAW) (board member from 2011-2016). He is member of the Koninklijke Hollandse Maatschappij van Wetenschappen (KHMW), the Academy for Technology and Innovation (ACTI), and founding member of HDMT and EUROoCS, the European Organ on Chip Society. From 2014-2018 he was scientific director of the MIRA institute for Biomedical Engineering. In 2017 he became co-PI of the Max Planck - University of Twente Center for Complex Fluid Dynamics. In 2018 he became (co)director of MESA+ institute for Nanotechnology.
Round Table
MODERATOR
PANELISTS
.jpeg)
André Albergaria
​
Head of the IPATIMUP Translational Research Unit.
i3S, Porto, Portugal
Bruno Sarmento
​
Principal Investigator and Group Leader of the Nanomedicines and Translational Drug Delivery group.
i3S, Porto, Portugal
Teófilo Vasconcelos
​
Head of Pharmaceutical Sciences.
BIAL, Porto, Portugal
José Dinis
​
Oncologist and Coordinator of the Clinical Research Unit.
IPO, Porto, Portugal
Program
8:45
REGISTRATION
Foyer of Auditorium Mariano Gago
14:30
CATARINA BRITO
iBET/ITQB, Nova University Lisboa, Portugal
Auditorium Mariano Gago
9:15
WELCOME SESSION
BiotechHealth 6th edition students
Auditorium Mariano Gago
15:15
BIOTECHHEALTH ALUMNI SESSION
Ana C. Silva
(Gladstone Institutes, San Francisco, USA)
Auditorium Mariano Gago
9:30
JOÃO F. MANO
CICECO, University of Aveiro, Portugal
Auditorium Mariano Gago
10:15
PLATINUM SPONSOR SESSION
Maria Wurm
Founder of Magellan Biologics & Consulting (Portugal) and CEO of ExcellGene, SA (Switzerland)
Auditorium Mariano Gago
15:45
COFFEE BREAK
i3S Canteen
16:15
ALBERT VAN DEN BERG
MESA+ Institute for Nanotechnology,
University of Twente, Netherlands
Auditorium Mariano Gago
10:40
LORENA DIÉGUEZ
INL, Braga, Portugal
Auditorium Mariano Gago
11:25
COFFEE BREAK
i3S Canteen
17:00
ROUND TABLE
Bruno Sarmento (i3S, Porto, Portugal)
Teófilo Vasconcelos (BIAL, Porto, Portugal)
José Dinis (IPO, Porto, Portugal)
Moderator: André Albergaria (i3S, Porto, Portugal)
Auditorium Mariano Gago
12:40
MARÍA J. ALONSO
University of Santiago de Compostela, Spain
Auditorium Mariano Gago
11:55
BRUNO SILVA-SANTOS
iMM, Lisbon, Portugal
Auditorium Mariano Gago
18:00
CLOSING SESSION
Mário Barbosa (BiotechHealth director/i3S,
Porto, Portugal)
Auditorium Mariano Gago
13:25
LUNCH
i3S Canteen and Maria de Sousa Library
Sponsors
PLATINUM SPONSORS
SILVER SPONSORS
GOLD SPONSORS
SPONSORS
The Venue
i3S – Instituto de Investigação e Inovação em Saúde
Address: Rua Alfredo Allen, 208; 4200-135 Porto, Portugal
GPS coordinates: 41º 10’ 30.008’’ N, 8º 36’ 12.488’’ W
Site: http://www.i3s.up.pt/ E-mail: info@i3s.up.pt Tel: +351 220 408 800
GET IN TOUCH
#BIOTECHHEALTH2020
